Management of Tinea Corporis

Diagnostic Confirmation

The American Academy of Dermatology recommends obtaining potassium hydroxide (KOH) preparation or fungal culture before initiating treatment to confirm dermatophyte infection and identify the causative organism 2
Culture specimens on Sabouraud agar if KOH is negative but clinical suspicion remains high, as recommended by the British Association of Dermatologists 3

The American College of Dermatology recommends topical terbinafine 1% cream applied once daily for 1-2 weeks as first-line therapy for localized tinea corporis 1, 2
Alternative topical options include naftifine 1% once daily for 1-2 weeks, as suggested by the American Academy of Dermatology 1

The Infectious Diseases Society of America recommends systemic therapy for extensive or large body surface area infections, treatment failure, or immunocompromised patients 1, 2
The American Academy of Pediatrics recommends terbinafine 250 mg daily for 1-2 weeks, achieving an 87.1% mycological cure rate 4, 5, 2
The American College of Dermatology recommends itraconazole 100 mg daily for 15 days, achieving an 87% mycological cure rate 4, 5, 1

The American Academy of Dermatology recommends mycological cure (negative microscopy and culture) as the definitive treatment endpoint 1, 2
Repeat mycology sampling at the end of standard treatment period and continue monthly until mycological clearance is documented, as suggested by the American College of Dermatology 1

The Centers for Disease Control and Prevention recommend screening and treating all household contacts, as over 50% may be affected with anthropophilic species like T. tonsurans 2
The American Academy of Pediatrics recommends cleaning all fomites (combs, brushes, towels, clothing) with disinfectant or 2% sodium hypochlorite solution 4, 5
The American College of Dermatology recommends applying antifungal powders (miconazole, clotrimazole, tolnaftate) to prevent reinfection in high-risk individuals 1

The American Heart Association recommends avoiding itraconazole in heart failure due to significant drug interactions 1
The American College of Dermatology recommends baseline liver function tests before initiating oral terbinafine or itraconazole, especially with pre-existing hepatic abnormalities 1
The British Association of Dermatologists recommends terbinafine for Trichophyton species and griseofulvin for Microsporum species if organism-directed therapy is needed 3, 1

The American Academy of Dermatology recommends assessing compliance, drug absorption, and potential reinfection sources if initial therapy fails 3
The British Association of Dermatologists recommends continuing current therapy for an additional 2-4 weeks if clinical improvement occurs but mycology remains positive 3
The American College of Dermatology recommends switching to alternative oral agent: use itraconazole if terbinafine failed, or terbinafine if azole failed 3, 2